The next generation of reagents for genetic research
Capture sequence-specific nucleic acids
About our Technology
Only the DNA or RNA you are looking for
Our solutions are based on a novel variety of magnetic nanoparticles, which can capture any given DNA/RNA molecule in a sequence specific manner.
The new reagents are particularly efficient for methylation studies, interactome analysis, and targeted sequencing with 2nd and 3rd generation sequencing platforms.
SARS-CoV-2 viral RNA capture
SARS-CoV-2 MagIC Beads (Magnetic Instant Capture Beads) is designed for capturing long viral RNA molecules directly from biological samples for high-throughput sequencing, interactome analysis, and chemical modification studies.
Sequence-specific RNA capture
MagIC Beads can capture any RNA of interest.
As a custom-target solution, it is designed for capturing long RNA molecules directly from biological samples for high-throughput sequencing, interactome analysis, and chemical modification studies.
Connect with ElementZero Biolabs
Are you researching difficult RNA targets, COVID-19 or any RNA studies?
ElementZero wants to help you! Get in touch.
The next generation of technology for genetic research
At ElementZero Biolabs, we know that genetics is the gatekeeper to the future of medicine.
Our mission is to provide technology to unlock the potential of genetics for diagnosis and treatment.
We foster scientific research.
John Moura
CEO & Co-Founder
John is an engineer by training who has spent the last 10+ years launching products across the world. John has led multidisciplinary teams, covering Product, Operations and Marketing & Sales in global companies such as Wunder Mobility.
Dr. Karol Rogowski
CSO & Co-Founder
Karol holds a Ph.D. in Biochemistry from the Max Delbrück Center and the Free University of Berlin. Karol has over 10 years of experience in RNA research whilst working for some of the world’s leading academic labs.
Eric Blair
Commercial Advisor
Eric has 20+ years of experience in the Life Science, Precision Medicine, and Pharmaceutical markets. Eric has led commercial teams in companies like ThermoFisher and Metabolon, currently being the CCO at Argonaut Manufacturing Services.
David Ford Strategic Advisor
David has 20+ years of experience as a life-sciences investor. David is a former Managing Director at Intermediate Capital Group plc and former Investment Director at Pricoa Private Capital, currently being the chairman at Somaserve.
Supported by
